Thiraporn Kanjanaphan

Dr. Thiraporn Kanjanaphan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2023 in Oxford Medical Case Reports
Verified
Journal Article
Open access
PDF file
WIWirapatra Iamwat
Wirapatra Iamwat
KCKrit Cheawcharnprapan
Krit Cheawcharnprapan
PYPatcha Yenjabog
Patcha Yenjabog
OLOranooj Lertkovit
Oranooj Lertkovit
DIDaranee Isaranimitkul
Daranee Isaranimitkul
TKThiraporn Kanjanaphan
Thiraporn Kanjanaphan
This case report highlights the infrequent occurrence of coinfection involving invasive aspergillosis and Mycobacterium tuberculosis (MTB) in pediatric patients. We present the case of a 9-year-old Thai girl diagnosed with B-cell acute lymphoblastic leukemia, who experienced prolonged febrile neutropenia lasting 1 month during chemotherapy. Chest computed tomography (CT) revealed lung nodules with an air crescent sign, while CT angiography of the brain detected an infected ruptured brain aneurysm, which exhibited septate hyphae with acute angle branching, consistent with invasive aspergillosis. Despite voriconazole treatment, the patient’s high-grade fever and dyspnea persisted. Further investigations revealed a lung abscess and wedge resection confirmed AFB 1+ and positive MTB detection via polymerase chain reaction, leading to the initiation of combined treatment for pulmonary tuberculosis and invasive aspergillosis. Considering drug–drug interactions was an essential aspect of the management. This case report highlights challenges of coinfection between invasive aspergillosis and MTB.

31 October 2024 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
KCKrit Cheawcharnpraparn
Krit Cheawcharnpraparn
TKThiraporn Kanjanaphan
Thiraporn Kanjanaphan
OLOranooj Lertkovit
Oranooj Lertkovit
NPNapaporn Puripat
Napaporn Puripat
CCChutima Chavanisakun
Chutima Chavanisakun
STSirikarn Tangcheewinsirikul
Sirikarn Tangcheewinsirikul
Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation that results in an uncontrolled hyperinflammatory state. HLH is classified into two main categories: primary (familial) HLH and secondary (acquired) HLH. Secondary HLH can result from various underlying, including infection-associated hemophagocytic syndrome (IAHS) and macrophage activation syndrome (MAS) associated with rheumatologic disorders, among others. Epstein–Barr virus (EBV) often causes IAHS, but central nervous system (CNS) involvement is rare among systemic lupus erythematosus (SLE) patients. We report a case of EBV encephalitis associated with HLH in a patient with childhood-onset SLE. A 12-year-old girl had received a diagnosis of SLE 2 months before presentation. After a period of inactive disease on treatment, fever and seizures, with altered mental status and hallucinations, developed over several weeks. A complete blood cell count (CBC) revealed pancytopenia, accompanied by elevated levels of inflammatory markers: 86 mm/hr erythrocyte sedimentation rate, 8.9 mg/dl c-reactive protein, and 3,966 ng/mL of ferritin. The differential diagnosis included active neuropsychiatric SLE, CNS infection and neurological manifestations in secondary HLH, which could have represented either IAHS or MAS. Meropenem and acyclovir were initially administered for clinical acute encephalitis, followed by pulse methylprednisolone; however, the fever persisted, and another CBC revealed progressive cytopenia. A bone marrow study showed hypocellularity and active hemophagocytic activity, and intravenous immunoglobulin was additionally given due to the diagnosis of HLH. Cerebrospinal fluid (CSF) analysis showed 60/mm3 white blood cells (N 55%, L 45%), 141 mg/dL glucose (0.7 blood-CSF glucose ratio), < 4 mg/dL protein; results of Gram stain and bacterial culture were negative. The viral encephalitis panel from the CSF confirmed EBV infection. Bone marrow immunohistochemistry examination revealed increasing levels of CD8 + T-cell and equivocal positive results for EBV-encoded RNA in situ hybridization; therefore, HLH potentially associated with EBV was diagnosed. After treatment with IVIg, cyclosporin A, and prednisolone, the patient’s symptoms gradually improved and she was eventually able to return to school. Our case highlights the importance of a thorough differential diagnosis, including EBV encephalitis associated with HLH, in patients with childhood SLE, particularly in cases of clinical deterioration occurs after initial treatment.

26 April 2024 in IDCases
Verified
Journal Article
Open access
STSirikarn Tangcheewinsirikul
Sirikarn Tangcheewinsirikul
WPWeena Phuthongkam
Weena Phuthongkam
TKThiraporn Kanjanaphan
Thiraporn Kanjanaphan


30 December 2025 in Infectious Diseases in Clinical Practice
Verified
Journal Article
Closed access
MPMaysa Pattrayuttawat
Maysa Pattrayuttawat
TKThiraporn Kanjanaphan
Thiraporn Kanjanaphan
Introduction: Influenza poses a significant risk of mortality among pediatric patients. However, the specific risk factors associated with severe influenza in children are not well-defined. Clarifying these factors is crucial for improving preventive strategies against infection. Methods: This retrospective study analyzed pediatric patients under 15 years old who were diagnosed with influenza infection at Vajira Hospital from January 1, 2018, to December 31, 2022. Multivariate analysis was utilized to identify factors associated with severe influenza. Results: The 5-year retrospective study revealed that 300 pediatric patients were diagnosed with influenza infection. The median age was 4 months (interquartile range, 2.00–8.75 months), with 50% of patients being female. Among them, 80 patients (26.67%) had underlying diseases, with chronic lung disease being the most prevalent (22 patients, 7.33%). Notably, 94% of the patients had not received the influenza vaccine. Severe influenza was found in 56 patients (18.67%). Underlying diseases (odds ratio, 7.37; P < 0.001), especially chronic lungs disease (adjusted odds ratio, 45.286; P < 0.001) and nosocomial infection (adjusted odds ratio, 3.29; P = 0.019) were identified as factors associated with severe influenza. Conclusions: One-fifth of pediatric influenza cases exhibited severe manifestations, with underlying diseases and nosocomial infection identified as significant risk factors for severe influenza. Close monitoring is warranted for these patients, and infection control measures should be emphasized to prevent nosocomial infections.

18 March 2024 in Journal of Pediatrics & Neonatal Care
Verified
Journal Article
Open access
PDF file
PSPichada Saengrat
Pichada Saengrat
OSOrnatcha Sirimongkolchaiyakul
Ornatcha Sirimongkolchaiyakul
TKThiraporn Kanjanaphan
Thiraporn Kanjanaphan
This case presents a challenging scenario in a preterm female newborn born at 25 weeks gestation,who developed respiratory distress syndrome, followed by pneumonia, sepsis, subsequent renal complications, and candida albicans infection. Despite initial susceptibility to fluconazole, the emergence of fluconazole-resistant candida albicans led to a shift in antifungal treatment to amphotericin B in an acute kidney injury neonate. This case underscores the growing concern of drug-resistant candida albicans in neonates, highlighting the importance of judicious selection of empirical antifungal therapy and comprehensive management strategies, especially in the context of acute kidney injury.